Table 3 Treatment outcome from Papua and Sumatra Islands during the 42 days of follow up
Classification of treatment outcome | Papua | Sumatra | ||||||
|---|---|---|---|---|---|---|---|---|
P. falciparum | P. vivax | P. vivax | ||||||
n | % (95% CI)# | n | % (95% CI) | n | % (95% CI) | |||
Total patient’s treatment failure and completed the 42 day follow up | Treatment Failure | ETF | 0 | – | 0 | – | 0 | – |
LCF | 0 | – | 0 | – | 0 | – | ||
LPF | 7 | 6.9% (2.8–13.6) | 9 | 11.3% (5.3–20.3) | 1 | 2.9% (0.1–15.3) | ||
ACPR | 95 | 93.1% (86.4–97.2) | 71 | 88.8% (79.7–94.7) | 33 | 97.1% (84.7–99.9) | ||
Patients LFU/WTH | 12 | – | 1 | – | 1 | – | ||
Total patients at baseline | 114 | – | 81 | – | 35 | – | ||